NuPathe Gets $114M Takeover Bid After Inking Deal With Endo
Specialty pharmaceuticals company NuPathe Inc. received a $114.3 million takeover bid from Israel-based Teva Pharmaceutical Industries Ltd., less than a month after NuPathe agreed to sell itself to Endo Health Solutions...To view the full article, register now.
Already a subscriber? Click here to view full article